Get the Stockscreener App
7.70
1.16%
-0.09
89 Bio Inc stock is traded at $7.70, with a volume of 1.27M.
It is down -1.16% in the last 24 hours and up +38.99% over the past month.
89bio Inc is a United States-based clinical-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its product candidate, pegozafermin (previously BIO89-100), a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (FGF21), is currently being developed for the treatment of nonalcoholic steatohepatitis (NASH) and for the treatment of severe hypertriglyceridemia (SHTG).
See More
Previous Close:
$7.79
Open:
$7.79
24h Volume:
1.27M
Relative Volume:
0.70
Market Cap:
$1.27B
Revenue:
-
Net Income/Loss:
$-174.61M
P/E Ratio:
-3.9086
EPS:
-1.97
Net Cash Flow:
$-165.54M
1W Performance:
-11.80%
1M Performance:
+38.99%
6M Performance:
-26.32%
1Y Performance:
-15.48%
1-Day Range:
$7.67
$7.98
1-Week Range:
$7.40
$8.80
52-Week Range:
$4.16
$11.84
89 Bio Inc Stock (ETNB) Company Profile
Name
89 Bio Inc
Sector
Industry
Phone
(415) 432-9270
Address
655 MONTGOMERY STREET, SAN FRANCISCO, CA
Compare ETNB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ETNB
89 Bio Inc
|
7.70 | 1.27B | 0 | -174.61M | -165.54M | -1.97 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.99 | 128.84B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
527.78 | 65.38B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
549.65 | 39.67B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
251.15 | 33.82B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
231.99 | 27.60B | 3.81B | -644.79M | -669.77M | -6.24 |
89 Bio Inc Stock (ETNB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-14-25 | Initiated | Goldman | Neutral |
| Mar-13-25 | Initiated | Citigroup | Buy |
| Feb-04-25 | Initiated | Wolfe Research | Outperform |
| Apr-22-24 | Resumed | BofA Securities | Buy |
| Jan-12-24 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Oct-10-23 | Downgrade | Oppenheimer | Outperform → Perform |
| Aug-28-23 | Initiated | UBS | Buy |
| Jun-13-23 | Initiated | Evercore ISI | Outperform |
| May-12-22 | Upgrade | Raymond James | Outperform → Strong Buy |
| Dec-20-21 | Initiated | H.C. Wainwright | Buy |
| Oct-26-21 | Resumed | Cantor Fitzgerald | Overweight |
| Jul-29-21 | Resumed | BTIG Research | Buy |
| May-25-21 | Downgrade | Raymond James | Strong Buy → Outperform |
| Apr-21-21 | Initiated | Cantor Fitzgerald | Overweight |
| Oct-19-20 | Initiated | Raymond James | Strong Buy |
| Sep-25-20 | Upgrade | BofA Securities | Neutral → Buy |
| Jul-31-20 | Initiated | Piper Sandler | Overweight |
| Jul-23-20 | Initiated | BTIG Research | Buy |
| Jul-07-20 | Initiated | Chardan Capital Markets | Buy |
| Dec-09-19 | Initiated | BofA/Merrill | Neutral |
| Dec-09-19 | Initiated | Oppenheimer | Outperform |
| Dec-09-19 | Initiated | RBC Capital Mkts | Outperform |
| Dec-09-19 | Initiated | SVB Leerink | Outperform |
View All
89 Bio Inc Stock (ETNB) Latest News
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
89bio, Inc. (NASDAQ:ETNB) Receives $27.25 Consensus Target Price from Analysts - Defense World
Deeper Dive: Understanding 89bio Inc (ETNB) Through its Various Ratios - DWinneX
MetLife Investment Management LLC Raises Stake in 89bio, Inc. (NASDAQ:ETNB) - Defense World
89bio to Participate in Upcoming Investor Conferences - The Manila Times
89bio Schedules Double Fireside Chats: Key Updates Coming at Major Healthcare Conferences - Stock Titan
89bio Inc. Reports Q1 2025 Financial Results - TipRanks
Invesco Ltd. Acquires 3,893 Shares of 89bio, Inc. (NASDAQ:ETNB) - Defense World
Wells Fargo & Company MN Has $394,000 Position in 89bio, Inc. (NASDAQ:ETNB) - Defense World
Brokers Offer Predictions for 89bio FY2025 Earnings - Defense World
Decoding 89bio Inc (ETNB): A Strategic SWOT Insight - GuruFocus
89bio, Inc. SEC 10-Q Report - TradingView
89bio Inc [NASDAQ: ETNB] Sees Increase in Stock Value - knoxdaily.com
Cantor Fitzgerald cuts 89bio stock target to $55; keeps overweight By Investing.com - Investing.com Nigeria
Cantor Fitzgerald cuts 89bio stock target to $55; keeps overweight - Investing.com
89bio (ETNB) Poised for Success with Advancements in MASH Trials - GuruFocus
Cantor Fitzgerald Upgrades 89bio (NASDAQ:ETNB) to “Strong-Buy” - Defense World
89bio Reports First Quarter 2025 Financial Results and Corporate Updates - The Manila Times
There is no doubt that 89bio Inc (ETNB) ticks all the boxes. - Sete News
Insider’s View: Deciphering 89bio Inc (ETNB)’s Financial Health Through Ratios - DWinneX
Taking a Closer Look At 89bio Inc (ETNB) Following Its Recent Trade - knoxdaily.com
Legal & General Group Plc Sells 4,860 Shares of 89bio, Inc. (NASDAQ:ETNB) - Defense World
89bio, Inc. (NASDAQ:ETNB) Holdings Trimmed by Russell Investments Group Ltd. - Defense World
89bio’s (ETNB) “Sell (D-)” Rating Reiterated at Weiss Ratings - Defense World
89bio Inc [ETNB] stock for 91,208 USD was sold by Le-Nguyen Quoc - knoxdaily.com
89bio, Inc. (NASDAQ:ETNB) Shares Purchased by JPMorgan Chase & Co. - Defense World
Market Watch: 89bio Inc (ETNB)’s Noteworthy Gain, Closing at 6.55 - DWinneX
A look into 89bio Inc (ETNB)’s deeper side - Sete News
89bio Sees Unusually Large Options Volume (NASDAQ:ETNB) - Defense World
A year in review: 89bio Inc (ETNB)’s performance in the last year - uspostnews.com
Federated Hermes Inc. Acquires 4,236 Shares of 89bio, Inc. (NASDAQ:ETNB) - Defense World
Geode Capital Management LLC Grows Position in 89bio, Inc. (NASDAQ:ETNB) - Defense World
89bio: A Buy With Strong Market Opportunity In MASH And SHTG - Seeking Alpha
89bio’s chief technical operations officer sells $91,207 in stock By Investing.com - Investing.com India
89bio’s chief technical operations officer sells $91,207 in stock - Investing.com
89bio: Primary Asset Targeting 2 Potential Indications; In Late-Stage Development (ETNB) - Seeking Alpha
Vanguard Group Inc. Grows Stock Holdings in 89bio, Inc. (NASDAQ:ETNB) - Defense World
89bio, Inc. (NASDAQ:ETNB) Shares Bought by Wellington Management Group LLP - Defense World
89bio, Inc. (NASDAQ:ETNB) Shares Bought by American Century Companies Inc. - Defense World
Corebridge Financial Inc. Sells 3,141 Shares of 89bio, Inc. (NASDAQ:ETNB) - Defense World
89bio, Inc. (NASDAQ:ETNB) Given Average Recommendation of “Moderate Buy” by Analysts - Defense World
KLP Kapitalforvaltning AS Purchases New Holdings in 89bio, Inc. (NASDAQ:ETNB) - Defense World
89bio (NASDAQ:ETNB) Receives Sell (D-) Rating from Weiss Ratings - Defense World
Looking For A Good Stock? Let This 89bio Inc (NASDAQ: ETNB) Analysis Help. - stocksregister.com
89bio stock hits 52-week low at $5.96 amid market challenges - Investing.com Canada
89bio stock hits 52-week low at $5.96 amid market challenges By Investing.com - Investing.com South Africa
Teacher Retirement System of Texas Has $191,000 Holdings in 89bio, Inc. (NASDAQ:ETNB) - Defense World
Swiss National Bank Grows Position in 89bio, Inc. (NASDAQ:ETNB) - Defense World
Certain Warrants of 89bio, Inc. are subject to a Lock-Up Agreement Ending on 30-MAR-2025. - MarketScreener
Raymond James Financial Inc. Invests $2.95 Million in 89bio, Inc. (NASDAQ:ETNB) - Defense World
Certain Common Stock of 89bio, Inc. are subject to a Lock-Up Agreement Ending on 30-MAR-2025. - marketscreener.com
89 Bio Inc Stock (ETNB) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.84%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):